FIG 5.
Part of the sortable, searchable table for therapies in category 3 for a putative patient with estrogen receptor–positive breast cancer and FGFR1 overexpression, showing the subset of therapies that target MAP2K1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.